Corpus Intelligence IC Memo — MEM. HOSPT. OF SWEETWATER COUNTY 2026-04-26 15:04 UTC
IC Memo — MEM. HOSPT. OF SWEETWATER COUNTY
Investment Committee Memorandum | WY | 58 beds | Grade C | EBITDA uplift $7.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MEM. HOSPT. OF SWEETWATER COUNTY

CCN 530011 | SWEETWATER, WY | 58 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MEM. HOSPT. OF SWEETWATER COUNTY is a 58-bed under-performing / distressed in SWEETWATER, WY with $107.7M in net patient revenue and a -8.9% operating margin. The hospital serves a payer mix of 35.0% Medicare, 14.6% Medicaid, and 50.5% commercial.

Thesis: Turnaround. Our ML models identify $7.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.9% to -1.6% (+736bps).

Net Revenue HCRIS$107.7M
Current EBITDA COMPUTED$-9.6M
Operating Margin COMPUTED-8.9%
Occupancy HCRIS26.9%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS46.9%
Distress Probability ML57.1%

2. Market Context & Competitive Position

29
WY Hospitals
-7.5%
State Median Margin
8
Comparable Hospitals

WY has 29 Medicare-certified hospitals with a median operating margin of -7.5%. The target's margin of -8.9% places it below the state median. Among 8 size-comparable peers (29-116 beds), the median margin is 5.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (29-116), prioritizing same-state peers. 8 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MEM. HOSPT. OF SWEETWATER COUN (Target)WY58$107.7M-8.9%
CAMPBELL COUNTY MEMORIAL HOSPIWY66$179.4M-22.8%
ST. JOHNS HOSPITALWY48$169.8M-7.8%
MEM. HOSPITAL OF SHERIDAN CTY.WY88$139.0M-4.0%
IVINSON MEMORIAL HOSPITALWY76$128.5M9.0%
WYOMING STATE HOSPITALWY72$37.5M4.6%
EVANSTON REGIONALWY32$35.3M17.6%
WYOMNG BEHAVIORAL INSTITUTEWY85$20.9M6.5%
ELKHORN VALLEY REHABILITATION WY40$17.0M10.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.3M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$69K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.3M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.1M
A/R Days Reduction
$1.3M
Clean Claim Rate
$69K
Total EBITDA Uplift$7.9M
Current EBITDA$-9.6M
+ RCM Uplift+$7.9M
Pro Forma EBITDA$-1.7M
Current Margin-8.9%
Pro Forma Margin-1.6%
WC Released (1x)$4.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-14.8M$15.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-14.8M$12.7M0.00x-100.0%
Bull Case9.0x11.0x$-13.3M$34.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-13.3M$33.3M0.00x-100.0%
Bear Case11.0x10.0x$-16.3M$-18.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-16.3M$-26.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 26.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 8 hospitals with 29-116 beds
  • Same-state prioritization (n=9)
  • Comp margins: P25=-5.0% / P50=5.6% / P75=9.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.